Side-by-side comparison of AI visibility scores, market position, and capabilities
CVS Health-operated pharmacy inside Target (NYSE: TGT) stores serving 100M weekly shoppers; $1.9B 2015 Target-to-CVS pharmacy acquisition creating store-within-store pharmacy integrated with Target Circle loyalty.
Target Pharmacy refers to the pharmacy services within Target Corporation's (NYSE: TGT) retail stores — providing prescription dispensing, immunizations, and health consultations to Target shoppers combining pharmacy errands with retail shopping. In 2015, Target sold its pharmacy and clinic operations to CVS Health (NYSE: CVS) for $1.9 billion, converting the in-store locations to CVS Pharmacy branding under a long-term licensing agreement — making what shoppers call "Target Pharmacy" operationally a CVS pharmacy located inside Target's 1,900+ US stores, operating under CVS management while Target shoppers earn Target Circle rewards on eligible pharmacy purchases.
Indianapolis global pharma (NYSE: LLY) at $45B 2024 revenue (+32%); first healthcare company to $1T market cap (Nov 2024) with Mounjaro/Zepbound tirzepatide (37% revenue) and oral GLP-1 orforglipron Phase 3 competing with Novo Nordisk.
Eli Lilly and Company is an Indianapolis, Indiana-based global pharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: LLY) as an S&P 500 Dow Jones Industrial Average component — that in November 2024 became the world's most valuable pharmaceutical company with a historic $1 trillion market capitalization, the first healthcare company ever to reach this milestone. In fiscal year 2024, Lilly achieved approximately $45 billion in revenue, representing 32% growth from 2023, driven by blockbuster GLP-1 medications tirzepatide (Mounjaro for type 2 diabetes and Zepbound for obesity and obstructive sleep apnea), which together accounted for 37% of 2024 revenues. Other key products include Trulicity (dulaglutide, 12% of revenue), Humalog (insulin lispro, 5%), and Kisunla (donanemab), the first new Alzheimer's therapy approved for early symptomatic disease in 2024. An oral GLP-1 pill (orforglipron) is in Phase 3 clinical trials. CEO David Ricks has led the company since 2017. Founded in 1876 by Colonel Eli Lilly in Indianapolis, the company pioneered mass production of Jonas Salk's polio vaccine in 1955 and was among the first to produce human insulin using recombinant DNA technology.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.